Erlotinib Prevent Disease Recurrence in Early Stage EGFR Positive NSCLC Patients?
http://cancerGRACE.org/...
Dr. Joel Neal of Stanford University Medical Center discusses the SELECT clinical trial which studied early stage non-small cell lung cancer patients and whether or not Tarc...
Author: cancergrace
Added: 05/20/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Clinical Trials | Lung Cancer | Non-Small Cell Lung Cancer | Tarceva